Notable Resmed Insider Trades $2.9M In Company Stock

Comments
Loading...

Robert Douglas President And Chief Operating Officer, Resmed Inc., COO at Resmed RMD, made a large buy and sell of company shares on November 15, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Robert Douglas President And Chief Operating Officer, Resmed Inc. exercised options to purchase 8,000 Resmed shares at a price of $58.24 per share for a total of $465,920 on November 15. They then sold their shares on succeeding transactions in the open market. They sold at prices ranging from $259.47 to $271.75 to raise a total of $2,419,199 from the stock sale.

Following the transaction, Inc. still owns 231,673 shares of Resmed worth $61,311,494.

Resmed shares are trading up 0.87% at $264.65 at the time of this writing on Tuesday morning.

The Importance of Insider Transactions

Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.

In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

Transaction Codes To Focus On

Investors prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.

Check Out The Full List Of Resmed's Insider Trades.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Overview Rating:
Good
62.5%
Technicals Analysis
100
0100
Financials Analysis
40
0100
Overview
Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!